The radioisotope contributes significantly to the activity of radioimmunotherapy.
Davis TA, Kaminski MS, Leonard JP, Hsu FJ, Wilkinson M, Zelenetz A, Wahl RL, Kroll S, Coleman M, Goris M, Levy R, Knox SJ.
Davis TA, et al. Among authors: hsu fj.
Clin Cancer Res. 2004 Dec 1;10(23):7792-8. doi: 10.1158/1078-0432.CCR-04-0756.
Clin Cancer Res. 2004.
PMID: 15585610
Clinical Trial.